These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15820277)

  • 1. Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors.
    Adson DE; Kushner MG; Fahnhorst TA
    J Affect Disord; 2005 May; 86(1):99-104. PubMed ID: 15820277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.
    Nelson JC; Mankoski R; Baker RA; Carlson BX; Eudicone JM; Pikalov A; Tran QV; Berman RM
    J Affect Disord; 2010 Jan; 120(1-3):133-40. PubMed ID: 19656577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients.
    Worthington JJ; Kinrys G; Wygant LE; Pollack MH
    Int Clin Psychopharmacol; 2005 Jan; 20(1):9-11. PubMed ID: 15602109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
    Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
    J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
    Papakostas GI; Petersen TJ; Kinrys G; Burns AM; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
    J Clin Psychiatry; 2005 Oct; 66(10):1326-30. PubMed ID: 16259548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression.
    Rutherford B; Sneed J; Miyazaki M; Eisenstadt R; Devanand D; Sackeim H; Roose S
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):986-91. PubMed ID: 17340654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
    Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
    CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
    Fava M; Mischoulon D; Iosifescu D; Witte J; Pencina M; Flynn M; Harper L; Levy M; Rickels K; Pollack M
    Psychother Psychosom; 2012; 81(2):87-97. PubMed ID: 22286203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy.
    Nelson JC; Rahman Z; Laubmeier KK; Eudicone JM; McQuade RD; Berman RM; Marcus RN; Baker RA; Sheehan JJ
    CNS Spectr; 2014 Dec; 19(6):528-34. PubMed ID: 24642260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: a subgroup analysis and Montgomery-Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study.
    Ozaki N; Otsubo T; Kato M; Higuchi T; Ono H; Kamijima K;
    Psychiatry Clin Neurosci; 2015 Jan; 69(1):34-42. PubMed ID: 24965202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study.
    Cheon EJ; Lee KH; Park YW; Lee JH; Koo BH; Lee SJ; Sung HM
    J Clin Psychopharmacol; 2017 Apr; 37(2):193-199. PubMed ID: 28129308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
    Menza MA; Dobkin RD; Marin H
    J Clin Psychopharmacol; 2007 Apr; 27(2):207-10. PubMed ID: 17414231
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
    Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
    Expert Opin Pharmacother; 2008 Dec; 9(18):3145-9. PubMed ID: 19040335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
    Sheffrin M; Driscoll HC; Lenze EJ; Mulsant BH; Pollock BG; Miller MD; Butters MA; Dew MA; Reynolds CF
    J Clin Psychiatry; 2009 Feb; 70(2):208-13. PubMed ID: 19210951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder.
    Matsunaga H; Hayashida K; Maebayashi K; Mito H; Kiriike N
    Int J Psychiatry Clin Pract; 2011 Nov; 15(4):263-9. PubMed ID: 22121999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of aripiprazole for depressed patients with an inadequate response to antidepressant treatment: a 6-week prospective, open-label, multicenter study.
    Jon DI; Kim DH; Seo HJ; Kwon YJ; Kim MD; Yang JC; Suh HS; Min KJ; Pae CU; Bahk WM
    Clin Neuropharmacol; 2013; 36(5):157-61. PubMed ID: 24045606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors.
    Adson DE; Kushner MG; Eiben KM; Schulz SC
    Depress Anxiety; 2004; 19(2):121-6. PubMed ID: 15022147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open study of aripiprazole and escitalopram for psychotic major depressive disorder.
    Matthews JD; Siefert C; Dording C; Denninger JW; Park L; van Nieuwenhuizen AO; Sklarsky K; Hilliker S; Homberger C; Rooney K; Fava M
    J Clin Psychopharmacol; 2009 Feb; 29(1):73-6. PubMed ID: 19142112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: a case series.
    Higuma H; Kanehisa M; Maruyama Y; Ishitobi Y; Tanaka Y; Tsuru J; Hanada H; Kodama K; Isogawa K; Akiyoshi J
    World J Biol Psychiatry; 2012 Jan; 13(1):14-21. PubMed ID: 22256827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.